Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.

Biotechnology

Education

Sonoma Biotherapeutics

Sonoma Biotherapeutics' headquarters in South San Francisco, CA, United States

This department oversees the strategic direction and governance of the organization through Board members.

Executive Governance

This department focuses on scientific research, experimentation, and the development of new products and processes.

Research and Development

The Scientific Research Team at Sonoma Biotherapeutics is responsible for advancing the understanding and development of engineered regulatory T cell therapies. This multidisciplinary team conducts cutting-edge research and experimentation to optimize Treg cell functionality, evaluates their therapeutic potential in preclinical models, and collaborates on innovative methods to induce immune tolerance. Their work is foundational to the development of novel treatments for autoimmune and inflammatory diseases, ensuring the translation of scientific discoveries into effective therapies.

Scientific Research Team

The Leadership Team at Sonoma Biotherapeutics is responsible for guiding the company's strategic vision and operational execution. Comprising key executives including the CEO, Chief Scientific Officer, and Chief Legal Officer, this team drives innovation in developing engineered Treg therapies, oversees financial and business strategies, ensures compliance, and fosters collaboration to advance the company's mission of treating autoimmune and inflammatory diseases effectively.

Leadership Team

The Clinical Operations Team at Sonoma Biotherapeutics is responsible for the planning, execution, and oversight of clinical trials for engineered regulatory T cell therapies. This team ensures compliance with regulatory requirements, coordinates multidisciplinary efforts, and manages project timelines and budgets to facilitate successful study outcomes. By collaborating closely with clinical development, regulatory affairs, and program management, they play a crucial role in advancing innovative treatments for autoimmune and inflammatory diseases.

Clinical Operations Team

The Finance and Accounting Team at Sonoma Biotherapeutics is responsible for overseeing the company's financial health, managing budgets, and ensuring compliance with accounting regulations. They play a critical role in strategic financial planning and analysis, supporting the development of innovative Treg therapies through sound fiscal management. Additionally, the team collaborates on resource allocation and financial reporting to enable effective decision-making across the organization.

People (7)

Jobs (0)

Other teams

Research and Development

Scientific Research Team

Leadership Team

Clinical Operations Team

Finance and Accounting Team